Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Boehringer Ingelheim
Queensland Health
UBS
Covington
Baxter
Federal Trade Commission
Daiichi Sankyo

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,858,662

« Back to Dashboard

Which drugs does patent 7,858,662 protect, and when does it expire?

Patent 7,858,662 protects VEREGEN and is included in one NDA.

This patent has twenty-nine patent family members in twenty countries.
Summary for Patent: 7,858,662
Title:Medicament for the treatment of viral skin and tumour diseases
Abstract: The invention relates to a medicament containing a compound of general formula (1), where R.sub.1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C.sub.11-C.sub.21 alkyl, alkylene or alkynyl group, preferably a C.sub.11-C.sub.15 alkyl, alkylene or alkynyl group, particularly a C.sub.11-C.sub.13 alkyl, alkylene or alkynyl group, most preferably a C.sub.13 alkyl group, R2=independently, a straight or branched C.sub.1-C.sub.8 alkyl, alkylene or alkynyl group, preferably a C.sub.1-C.sub.6 alkyl, alkylene or alkynyl group, in particular a C.sub.2-C.sub.4 alkyl, alkylene or alkynyl group, most preferably a C.sub.3 alkyl group, a --[CH.sub.2--(CH.sub.2).sub.m--O].sub.nH group with n=1 to 10, preferably n=1 to 5, m=1 to 5, preferably m=1 to 3, a --CH.sub.2--[CH--(OH)].sub.p[CH.sub.2--(R.sub.3)]-- group, where R.sub.3=independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumor diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof. ##STR00001##
Inventor(s): Chang; Yunik (Sonoma, CA), Lathrop; Robert (Fort Collins, CO), Bohm; Erwin (Ladenburg, DE), Gander-Meisterernst; Irene (Stockdorf, DE), Greger; Regina (Iffeldorf, DE), Holldack; Johanna (Ebeltoft, DK), Moebius; Ulrich (Gauting-Unterbrunn, DE)
Assignee: MediGene AG (Planegg, DE)
Application Number:10/495,889
Patent Claim Types:
see list of patent claims
Compound; Formulation; Use;

Drugs Protected by US Patent 7,858,662

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Fougera Pharms Inc VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF GENITAL WARTS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,858,662

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany101 56 794Nov 19, 2001
PCT Information
PCT FiledNovember 18, 2002PCT Application Number:PCT/EP02/12919
PCT Publication Date:May 30, 2003PCT Publication Number: WO03/043628

Non-Orange Book US Patents Family Members for Patent 7,858,662

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,770,406 Medicament for the treatment of viral skin and tumour diseases ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Daiichi Sankyo
Argus Health
Covington
Federal Trade Commission
Medtronic
Express Scripts
Fuji
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.